001     131744
005     20240229105010.0
024 7 _ |a 10.1158/0008-5472.CAN-17-1923
|2 doi
024 7 _ |a pmid:29070616
|2 pmid
024 7 _ |a 0008-5472
|2 ISSN
024 7 _ |a 0099-7013
|2 ISSN
024 7 _ |a 0099-7374
|2 ISSN
024 7 _ |a 1538-7445
|2 ISSN
024 7 _ |a altmetric:28020770
|2 altmetric
037 _ _ |a DKFZ-2018-00050
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Zuo, Hui
|b 0
245 _ _ |a Results from the European Prospective Investigation into Cancer and Nutrition Link Vitamin B6 Catabolism and Lung Cancer Risk.
260 _ _ |a Philadelphia, Pa.
|c 2018
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521450627_7049
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Circulating pyridoxal-5'-phosphate (PLP) has been linked to lung cancer risk. The PAr index, defined as the ratio 4-pyridoxic acid/(pyridoxal + PLP), reflects increased vitamin B6 catabolism during inflammation. PAr has been defined as a marker of lung cancer risk in a prospective cohort study, but analysis of a larger numbers of cases are needed to deepen the significance of this study. Here, we conducted a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC, n = 521,330), which included 892 incident lung cancer cases and 1,748 controls matched by center, gender, date of blood collection, and date of birth. The association of PAr with risk of lung cancer was evaluated by using conditional logistic regression. Study participants with elevated PAr experienced higher risk of lung cancer in a dose-response fashion, with a doubling in PAr levels associated with 52% higher odds of lung cancer after adjustment for tobacco smoking, serum cotinine levels, educational attainment, and BMI [OR, 1.52; 95% confidence interval (CI) 1.27-1.81; P < 0.001]. Additional adjustment for intake of vegetables and fruits and physical activity did not materially affect risk association. The association of PAr with lung cancer risk was similar in both genders but slightly stronger in former smokers and in participants diagnosed with squamous cell carcinoma. This study provides robust evidence that increased vitamin B6 catabolism is independently associated with a higher risk of future lung cancer.Significance: This large cohort study firmly establishes an association between an index of vitamin B6 levels with lung cancer risk. Cancer Res; 78(1); 302-8. ©2017 AACR.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Ueland, Per M
|b 1
700 1 _ |a Midttun, Øivind
|b 2
700 1 _ |a Vollset, Stein E
|b 3
700 1 _ |a Tell, Grethe S
|b 4
700 1 _ |a Theofylaktopoulou, Despoina
|b 5
700 1 _ |a Travis, Ruth C
|b 6
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 7
700 1 _ |a Fournier, Agnès
|b 8
700 1 _ |a Severi, Gianluca
|b 9
700 1 _ |a Kvaskoff, Marina
|b 10
700 1 _ |a Boeing, Heiner
|b 11
700 1 _ |a Bergmann, Manuela M
|b 12
700 1 _ |a Turzanski-Fortner, Renée
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 13
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 14
|u dkfz
700 1 _ |a Trichopoulou, Antonia
|b 15
700 1 _ |a Kotanidou, Anastasia
|b 16
700 1 _ |a Lagiou, Pagona
|b 17
700 1 _ |a Palli, Domenico
|b 18
700 1 _ |a Sieri, Sabina
|b 19
700 1 _ |a Panico, Salvatore
|b 20
700 1 _ |a Bueno-de-Mesquita, H Bas
|b 21
700 1 _ |a Peeters, Petra H
|b 22
700 1 _ |a Grankvist, Kjell
|b 23
700 1 _ |a Johansson, Mikael
|b 24
700 1 _ |a Agudo, Antonio
|b 25
700 1 _ |a Garcia, Jose Ramon Quiros
|b 26
700 1 _ |a Larranaga, Nerea
|b 27
700 1 _ |a Sanchez, Maria-Jose
|b 28
700 1 _ |a Chirlaque, Maria Dolores
|b 29
700 1 _ |a Ardanaz, Eva
|b 30
700 1 _ |a Chuang, Shu-Chun
|b 31
700 1 _ |a Gallo, Valentina
|b 32
700 1 _ |a Brennan, Paul
|b 33
700 1 _ |a Johansson, Mattias
|b 34
700 1 _ |a Ulvik, Arve
|b 35
773 _ _ |a 10.1158/0008-5472.CAN-17-1923
|g Vol. 78, no. 1, p. 302 - 308
|0 PERI:(DE-600)2036785-5
|n 1
|p 302 - 308
|t Cancer research
|v 78
|y 2018
|x 1538-7445
909 C O |o oai:inrepo02.dkfz.de:131744
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER RES : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER RES : 2015
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21